This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...

This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...

Looking back on papers published in high profile journals over the years, the path to publication has become ever more involved. The number of...

Each week Brian Britt, veteran Union Tribune radio host, interviews the San Diego’s best and brightest, thought leaders and visionaries for his...

Core labs at academic institutes lower the barrier to expensive technology and give people access to techniques outside their field of expertise...

Over the past few weeks we have covered a series of blogs from Steve Blank, the Silicon Valley serial-entrepreneur and academician who is...

Targeted based drug discovery has been a mainstay of pharmaceutical pipelines for the last 20 years. Identifying and validating novel drug...

Its been a wonderfully busy few months for Scientist and awards! In July, we were given a CIO award, a Pharmavoice 100 award. In August, we were...

Steve Blank wrote an excellent 3 part blog series last week. We covered Part 1 which described the challenges Life Science companies face in...

The US giant has been given a virtual outsourcing platform for Pfizer scientists called the MXIS (Market Exchange for Innovative Services) via...